Chief Executive Officer
CurrentCEO & Founder of Enumera Molecular, a life science tools company developing a single molecule detection platform capable of rapid, low cost assessment of biomolecules via liquid biopsy.
Apr 2022 - Present
AeroLeads people directory · profile
Matthew Cooper Email & Phone Number
Chief Executive Officer at Enumera Molecular
at
Enumera Molecular
2 work emails found
@enumeramolecular.com
2 phones found area 415
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer at Enumera Molecular
Location
Palo Alto, California, United States
Who is Matthew Cooper? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Matthew Cooper is listed as Chief Executive Officer at Enumera Molecular at Enumera Molecular, based in Palo Alto, California, United States. AeroLeads shows a work email signal at enumeramolecular.com, phone signal with area code 415, and a matched LinkedIn profile for Matthew Cooper.
Matthew Cooper previously worked as Chief Executive Officer at Enumera Molecular and Board Member at Avails Medical, Inc.. Matthew Cooper holds Mba, Finance, General from Columbia Business School.
Company email context
Email format at Enumera Molecular
This section adds company-level context without repeating Matthew Cooper's masked contact details.
{first}.{last}@enumeramolecular.com
89% confidence
AeroLeads found 2 current-domain work email signals for Matthew Cooper. Compare company email patterns before reaching out.
Profile bio
About Matthew Cooper
Matthew Cooper, Ph.D., MBA, is the Chief Executive Officer and Founder of Enumera Molecular, a life science tools company developing a single molecule detection platform capable of rapid, low cost assessment of biomolecules via liquid biopsy. A serial biotech entrepreneur, Matthew has experience starting several successful biotech/diagnostic/data science companies, mediating M&A transactions, IPO, scaling R&D organizations, and overseeing product development from discovery to launch on many commercial products in the life sciences.Matthew serves on the Board of Directors of Avials Medical, in addition to being a mentor to other life science entrepreneurs via StartX and an active Angel investor.Matthew has over 20 years experience in diagnostic, data science, and drug product development. Past areas of specialty have included biomarker discovery and development, data science, bioinformatics, safety (toxicology and DMPK), and organizational/corporate strategy.Matthew's educational background is as diverse as his professional experience with dual MBAs from Columbia Business School (Finance) and the Berkeley Haas School of Business (Entrepreneurship). Matthew also has a Ph.D. in Toxicology (University of Kentucky, College of Medicine) and a B.S. in Chemistry (University of Tulsa, College of Engineering). He is board certified in toxicology (Diplomat of the American Board of Toxicology) and has earned a Certificate of Entrepreneurship from the Berkeley Haas School of Business.In his downtime, Matthew is an avid foodie and wine collector.
Current workplace
Matthew Cooper's current company
Company context helps verify the profile and gives searchers a useful next step.
18 roles · 15 years
Matthew Cooper work experience
A career timeline built from the work history available for this profile.
Board Member
CurrentAvails Medical is developing solutions in accurate, rapid, and digital pathogen detection in bodily fluids to indicate effective drug treatments in real-time.For more information, visit https://availsmedical.com
Mar 2019 - Present
Adviser & Mentor
CurrentStartX is a collection of serial entrepreneurs, industry experts, tenured Stanford professors, and well-funded growth-stage startups brought together via a non-profit community. We believe that entrepreneurs can achieve more as a group, than we can as individuals. We help our companies hire elite talent, secure funding, and tap into one of the most.
Aug 2013 - Present
Board Member
Neoseq
- NeoSeq is developing advanced technologies and comprehensive services for global healthcare needs, inclduing:
- Complete solution for non-invasive prenatal diagnostics -Lowest cost cell free fetal DNA based screening -Most advanced fetal cell technology for disease confirmation
- Cancer diagnostics -Liquid biopsy analysis through ctDNA and CTC -Early cancer screening
- Health risk assessment -Inherited diseaseshttp://www.neoseqltd.com for more information.
Nov 2018 - Dec 2022
General Manager, Diagnostics
Progenity, Inc.
Full responsibility for all aspects of the Diagnostics business unit at Progenity.
Oct 2021 - Apr 2022
Chief Scientific Officer
Progenity, Inc.
Primary responsibilities include strategic and operational leadership of the R&D organization, Data Science, and IT. As Chairman of the corporate Portfolio Steering Committee, responsible for building an innovative product portfolio and pipeline, in addition to corporate strategy. During his tenure, Matt has lead an exceptionally productive R&D.
Apr 2015 - Apr 2022
Board Member
Member of the board of directors for a national patient advocacy organization, serving over 200,000 pregnany women each year who suffer from hypertensive disorders of pregnancy.
Mar 2014 - 2020
Advisor At Spark Translational Research Program
Evaluate IP from Stanford College of Medicine program for development and commercialization. http://sparkmed.stanford.edu/
2011 - 2019
~8 yrs
Advisor And Mentor To Lean Launchpad For Life Sciences & Healthcare
Advise Lean LaunchPad faculty on curriculum and business case applications of lean launchpad concepts in the life science industry.Mentor life science start-ups in the Lean LaunchPad program. Assist life start-up founders in commercializing their scientific discoveries via customer development and lean start-up.
Aug 2013 - Aug 2018
Ceo And Founder
Carmenta Bioscience
Acquired by Progenity Apr2015Founder and CEO of Carmenta Bioscience, a biotechnology company dedicated to addressing unmet medical needs in maternal and fetal health, with a focus on development and commercialization of diagnostic tests for preeclampsia. Co-founded by Atul Butte and Bruce Ling from Stanford School of Medicine.Raised >$2M in an.
Feb 2012 - Mar 2015
Chief Science Officer
- Responsible for translating customer's scientific and strategic needs into actionable software development goals. Other responsibilities include:
- Customer development
- Identification and management of strategic partnerships
- Corporate strategy
- Management of scientific talent
Feb 2010 - Feb 2012
Head Of Non-Clinical Safety Information
Responsible for leading all strategic and operational aspects of non-clinical safety information globally. Also responsible for identifying and collaborating with key technology partners in the industry and academia. Reported directly to Global Head of Non-Clinical Safety and served on the Core Global Leadership Team. Matthew also served on the RIST (Roche.
Jan 2009 - Apr 2010
Principal Research Scientist
Discovery & Investigative Safety group with Non Clinical Safety.My job responsibilities are 3-fold: 1. Lead early safety assessments for the therapeutic protein portfolio in Palo Alto. Act as immunosafety coordinator for site (50% effort).2. Lead the development and deployment of informatics strategies to support the Non Clinical Safety department; serve.
Feb 2006 - Jan 2009
Scientist Ii
Biomarker scientist, also group leader for Transcript Profiling and Computational Biology within Preclinical Development Sciences department.
Feb 2004 - Feb 2006
Scientist I
Project Toxicologist: worked on development teams to support drug registration activities. Tasks included designing, monitoring, and reporting of nonclinical safety studies, contributing to INDs and end of Phase II documents, and performing toxicogenomic and other investigational safety evaluations.
Feb 2001 - Feb 2004
Summer Intern
Worked with brokers to create portfolio reports for high wealth clients. Liaised with high wealth clients regarding biotechnology and pharmaceutical companies, providing “plain English” explanations of product pipelines.
May 1999 - Aug 1999
Summer Intern
Established the high-throughput “Ames II” assay for genotoxicity screening. Also cloned human cytochrome P450 enzymes into Ames bacterial strains to assist in the evaluation of human-specific mutagens.
Jun 1997 - Aug 1997
Summer Intern
Performed CHO cell chromosomal aberration assay in corporate toxicology group.
Jun 1996 - Aug 1996
4 education records
Matthew Cooper education
Mba, Finance, General
Columbia Business School
Mba, Entrepreneurship
University Of California, Berkeley, Haas School Of Business
Ph.D., Toxicology
University Of Kentucky College Of Medicine
B.S., Chemistry (College Of Engineering)
The University Of Tulsa
FAQ
Frequently asked questions about Matthew Cooper
Quick answers generated from the profile data available on this page.
What company does Matthew Cooper work for?
Matthew Cooper works for Enumera Molecular.
What is Matthew Cooper's role at Enumera Molecular?
Matthew Cooper is listed as Chief Executive Officer at Enumera Molecular at Enumera Molecular.
What is Matthew Cooper's email address?
AeroLeads has found 2 work email signals at @enumeramolecular.com for Matthew Cooper at Enumera Molecular.
What is Matthew Cooper's phone number?
AeroLeads has found 2 phone signal(s) with area code 415 for Matthew Cooper at Enumera Molecular.
Where is Matthew Cooper based?
Matthew Cooper is based in Palo Alto, California, United States while working with Enumera Molecular.
What companies has Matthew Cooper worked for?
Matthew Cooper has worked for Enumera Molecular, Avails Medical, Inc., Startx., Neoseq, and Progenity, Inc..
How can I contact Matthew Cooper?
You can use AeroLeads to view verified contact signals for Matthew Cooper at Enumera Molecular, including work email, phone, and LinkedIn data when available.
What schools did Matthew Cooper attend?
Matthew Cooper holds Mba, Finance, General from Columbia Business School.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial